Condensed Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Gain (Loss)	Accumulated Deficit
Balance at Dec. 31, 2021	$ 178,783	$ 3	$ 228,532	$ (10)	$ (49,742)
Balance (in shares) at Dec. 31, 2021		29,115,421
Exercise of stock options	31		31
Exercise of stock options, (in shares)		6,044
Issuance of restricted stock (in shares)		47,216
Stock-based compensation expense	2,330		2,330
Unrealized gain (loss) on investments, net	(13)			(13)
Net loss	(16,366)				(16,366)
Balance at Mar. 31, 2022	164,765	$ 3	230,893	(23)	(66,108)
Balance (in shares) at Mar. 31, 2022		29,168,681
Balance at Dec. 31, 2021	178,783	$ 3	228,532	(10)	(49,742)
Balance (in shares) at Dec. 31, 2021		29,115,421
Unrealized gain (loss) on investments, net	(7)
Net loss	(33,624)
Balance at Jun. 30, 2022	150,390	$ 3	233,770	(17)	(83,366)
Balance (in shares) at Jun. 30, 2022		29,280,131
Balance at Mar. 31, 2022	164,765	$ 3	230,893	(23)	(66,108)
Balance (in shares) at Mar. 31, 2022		29,168,681
Exercise of stock options	62		62
Exercise of stock options, (in shares)		9,366
Issuance of restricted stock (in shares)		47,216
Purchases under employee stock purchase plan	256		256
Purchases under employee stock purchase plan (in shares)		54,868
Stock-based compensation expense	2,559		2,559
Unrealized gain (loss) on investments, net	6			6
Net loss	(17,258)				(17,258)
Balance at Jun. 30, 2022	150,390	$ 3	233,770	(17)	(83,366)
Balance (in shares) at Jun. 30, 2022		29,280,131
Balance at Dec. 31, 2022	108,539	$ 3	240,107	(1)	(131,570)
Balance (in shares) at Dec. 31, 2022		29,561,554
Exercise of stock options	407		407
Exercise of stock options, (in shares)		44,501
Issuance of restricted stock (in shares)		45,079
Stock-based compensation expense	3,233		3,233
Unrealized gain (loss) on investments, net	1			1
Net loss	(29,051)				(29,051)
Balance at Mar. 31, 2023	83,129	$ 3	243,747		(160,621)
Balance (in shares) at Mar. 31, 2023		29,651,134
Balance at Dec. 31, 2022	$ 108,539	$ 3	240,107	$ (1)	(131,570)
Balance (in shares) at Dec. 31, 2022		29,561,554
Exercise of stock options, (in shares)	76,061
Unrealized gain (loss) on investments, net	$ 1
Net loss	(53,942)
Balance at Jun. 30, 2023	224,305	$ 4	409,813		(185,512)
Balance (in shares) at Jun. 30, 2023		35,630,276
Balance at Mar. 31, 2023	83,129	$ 3	243,747		(160,621)
Balance (in shares) at Mar. 31, 2023		29,651,134
Exercise of stock options	216		216
Exercise of stock options, (in shares)		31,560
Issuance of restricted stock			612
Issuance of restricted stock (in shares)		45,080
Purchases under employee stock purchase plan	612
Purchases under employee stock purchase plan (in shares)		152,502
Stock-based compensation expense	3,436		3,436
Issuance of common stock from public offering, net of offering costs	161,803	$ 1	161,802
Issuance of common stock from public offering, net of offering costs (in shares)		5,750,000
Net loss	(24,891)				(24,891)
Balance at Jun. 30, 2023	$ 224,305	$ 4	$ 409,813		$ (185,512)
Balance (in shares) at Jun. 30, 2023		35,630,276